Mangalore Refinery and Petrochemicals Ltd.'s share price slumped to the lowest level in over 10 months on Monday, as the company reported losses in the second quarter, compared to a profit in the corresponding quarter of the previous financial year. The company reported a loss of Rs 1,055 crore in July–September against Rs 1,597-crore profit.
Mangalore Refinery and Petrochemicals reported losses following operating loss on the back of high raw material costs and inventory costs. Its Ebitda loss stood at Rs 474 crore, a downslide from Rs 2,137 crore profit in the corresponding period of the previous financial year, it said in an exchange filing on Friday.
Inventory costs jumped 387.13% on the year to Rs 2,160 crore in July–September, from Rs 443 crore in the previous financial year, quarterly results indicated. Raw material costs increased 44.31% on the year to Rs 22,539.05 crore from Rs 15,618.08 crore.
However, the refinery company reported that its revenue rose 26.01% on the year to Rs 24,968 crore, from Rs 19,353 crore.
In the first half ended in September, Mangalore Refinery's net loss was at Rs 617 crore, compared to Rs 2,072 crore profit in the previous financial year. Its revenue rose 17.63% on the year to Rs 56,075 crore in the first half of the financial year 2025, from Rs 47,669 crore, the company said in an exchange filing.
Mangalore Refinery and Petrochemicals Share Price Today
Mangalore Refinery & Petrochemicals Ltd. share price declined 5.45% to Rs 156.51 apiece.
Mangalore Refinery & Petrochemicals Ltd. share price declined 5.45% to Rs 156.51 apiece.
Mangalore Refinery & Petrochemicals Ltd. share price declined 5.45% to Rs 156.51 apiece, the lowest level since Jan. 12. It was trading 4.37% lower at Rs 158.30 apiece as compared to 0.21% decline in the NSE Nifty 50.
The stock gained 66.92% in 12 months, and 20.16% on year-to-date basis. Total traded volume so far in the day stood at 4.2 times its 30-day average. The relative strength index was at 23.57, which implied the stock is oversold.
Out of four analysts tracking the company, one recommended a 'hold' and three suggested 'sell', according to Bloomberg data. The average 12-month consensus price target implies a downside of 2.8%.
RECOMMENDED FOR YOU
Brainbees Solutions Share Price Up Nearly 10% As Q2 Net Loss Narrows
Nov 18, 2024
Marico Share Price Surges As Q2 Profit Beats Forecasts
Oct 30, 2024
Federal Bank Share Price Jumps Most In Four Months As Asset Quality Remains Intact
Oct 29, 2024
CARE Ratings Share Price At Six Year High As Company Reports Strong Financial Growth In Q2 FY25
Oct 24, 2024
POPULAR